Honor the legacy of Anne Glauber
with a recurring gift
Anne Glauber, co-founder of Let’s Win, would have turned 67 on November 19th, World Pancreatic Cancer Day. When diagnosed, Anne struggled to find information on the latest treatments for pancreatic cancer. Her legacy is Let’s Win, where patients and doctors can share information about cutting-edge research and new treatments for this disease.
In honor of Anne, help us reach our goal of signing up 67 new recurring donors.
With your support, Let’s Win keeps growing, reaching more patients, sharing more of the latest science, and providing hope to all pancreatic cancer patients and their families.
Your monthly gift enables us to . . .
- Educate patients and families about innovative new treatments that extend lives.
- Ensure patients and caregivers receive information that is scientifically up-to-date and factually sound.
- Engage with patients, caregivers, doctors, and researchers on all Social Media platforms.
- Share information about ways patients can manage and improve their quality of life during treatment.
- Reach across barriers with a Spanish-language version of our website, and a partnership with the Elvin Howard Sr., Pancreatic Cancer Advocacy Foundation, to reach diverse patients and caregivers with information they need.
- Inspire hope through videos where patients meet long-term survivors and hear from scientists at the forefront of research for better treatments.
Let’s Win and Elvin Howard, Sr. PCAF Team Up for Pancreatic Cancer Awareness
The Elvin Howard, Sr. Pancreatic Cancer Advocacy Foundation (Elvin Howard, Sr. PCAF) and Let’s Win have released a new public service announcement to raise awareness of pancreatic cancer in people of color.
Identify Your Risk Early
After Scott Nelson was diagnosed with pancreatic cancer, his older brother Steve joined a pancreatic cancer screening study, knowing he and Scott carry the BRCA mutation. Being proactive about pancreatic cancer monitoring was the right move—Steve’s doctor was able to catch the disease in its earliest stages.